EXECUTIVE SUMMARY Global Pharma Industry is likely to grow at a CAGR of 5% to US $ 1 Trillion by 2013 The Pharmaceuticals Industry in India is the world’s 3 largest in terms of volume and stands 14th in terms of sale. Domestic pharma sector benefitted from increased thrust on Rural Health through bigger budgetary allocations in the Budget of 2009-10 According to PWC in 2010‚ India joined the league of Top 10 global pharmaceutical markets in terms of sales by 2020 with value reaching
Premium Pharmaceutical industry Generic drug
broadly be classified into two categories. Theses are a) Patent Medicines b) Generic Medicines Patent medicines are the products that are invented by the company‚ who have their own research team working on their own laboratories. These products are patented for many years to enjoy the monopoly market. After years of business the formulation is sold in the market so that others can go into mass production. Generic medicines are the products that are produced in mass scale. These are marketed
Premium Pharmaceutical industry Pharmacology Patent
pharmaceuticals ingredient (API) industrial park will be set at Gojaria Upazila of Munshiganj some 37 kilometers southeast of Dhaka‚ to co-operate the entrepreneurs of pharmaceutical sector. The Park would meet local demand and boost export of APIs and drugs. The API Park would make the country’s pharmaceutical industry cost effective and more competitive globally to help increase export of quality pharmaceuticals. The Park will secure long-term growth for the country ’s pharmaceutical sector. The park
Premium Pharmaceutical industry Pharmacology Generic drug
SUPPLY CHAIN SECTOR REPORT ON PHARMACEUTICAL INDUSTRY SRI SRI UNIVERSITY FACULTY OF MANAGEMENT STUDIES (2012-2014) SUBMITTED BY: Shyam Mohankar Priyansh Saxena Mrunalini Negi SUBMITTED TO: Dr.R.K .Padhy Contents 1.0 INTRODUCTION ....................................................................................................................................... 2 PHARMACEUTICAL SUPPLY CHAIN FLOW DIAGRAM .......................................................................
Premium Pharmaceutical industry Pharmacology Clinical trial
1.0 Gap Analysis I 1.1 Capability Gap Analysis The following Table 1 depicts the capability gap analysis of HP compared against its competitors namely Pharmaniaga‚ Kotra Pharma‚ Hovid and CCM Duopharma. The capabilities of competitors have been identified based on their recent annual reports and content posted in their respective websites. Table 1: Capability Gap Analysis Functional Area 1 Capability 2 Home Pharma Description of Home’s capability 3 Average the Capabilities of Closest two
Premium Strategic management Pharmaceutical industry Generic drug
Table of Contents 1.0 Introduction 2 2.0 Initial Situation – Case Analysis 2 2.1 The History of Bristol-Myers Squibb (BMS) 2 2.2 Peter R. Dolan 3 2.3 What is Plavix? 3 2.4 Plavix Generic Drug Agreements 4 2.5 Dolan’s Fate 5 3.0 Questions and Answers 6 3.1 Q1) What principles of distributive Negotiation did Sherman use to gain his advantage? 6 3.2 Q2 ) Do you think Sherman behaved ethically? Why or why not? 7 3.3 Q3) What does this incident tell you about the role of deception in negotiation
Premium Negotiation Generic drug
was an integrated‚ research based‚ international pharmaceutical company producing a wide range of quality‚ affordable generic medicines‚ trusted by healthcare professionals and patients across geographies. It was incorporated in 1961 by Singh’s grandfather Bhai Mohan Singh‚ further his son Dr. Parvinder Singh succeeded it‚ transforming Ranbaxy into India’s first multinational drug firm. It went public in 1973. In 1990 Ranbaxy Granted US patent for DoxyCyline. In 1992 Ranbaxy entered into an agreement
Premium Generic drug Ranbaxy Laboratories
Bioequivalence Study of Metformin Hydrochloride Tablets A Dissertation Submitted to the Vinayaka Missions University in Partial Fulfillment of the Requirement for the Degree of M.S. by Research in Pharmaceutical Technology By K. Kaliloor Rahman [Enrollment No. 172074 / 206081090084(New)] Under the Guidance of Mr. K. Senthilkumar M.Pharm (Industrial Pharmacy) Department of Pharmaceutical Chemistry‚ The Sarada Vilas College of Pharmacy Sarada Vilas Campus Krishanamurthypuram‚ Mysore -570004 (Karnataka)
Premium Pharmacology Pharmacokinetics Generic drug
2 Operations Strategy in a Global Environment PowerPoint presentation to accompany Heizer and Render Operations Management‚ 10e Principles of Operations Management‚ 8e PowerPoint slides by Jeff Heyl © 2011 Pearson Education‚ Inc. publishing as Prentice Hall 2-1 Developing Missions and Strategies Mission statements tell an organization where it is going The Strategy tells the organization how to get there © 2011 Pearson Education‚ Inc. publishing as Prentice Hall 2-2
Premium Product management Generic drug Pearson PLC
quality‚ affordable generic medicines across many countries. It has ground operations in 43 countries and 16 manufacturing units spread across 8 countries. Its market presence spreads over 25 pharmaceutical markets. Ranbaxy first attracted the attention of global pharmaceutical industry by creating relatively simple process to produce complex new drug molecule invented by Eli Lilly. Thus leading to Lilly outsourcing the production of this drug to Ranbaxy and later
Premium Generic drug Pharmaceutical industry Ranbaxy Laboratories